Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs10203530 | chr2:107235579 | G/A | 0.000239 | 176 | 26.57 | 23.53 | 25.87 | KM Plot |
PCPG | rs10204305 | chr2:24303173 | C/T | 0.000118 | 177 | 25.28 | 26.57 | 17.43 | KM Plot |
PCPG | rs10205979 | chr2:24335790 | A/G | 0.000114 | 177 | 25.4 | 26.92 | 17.43 | KM Plot |
PCPG | rs10207813 | chr2:24335111 | T/C | 0.000114 | 177 | 25.4 | 26.92 | 17.43 | KM Plot |
PCPG | rs10208832 | chr2:24292870 | G/A | 0.00011 | 178 | 25.4 | 26.57 | 17.43 | KM Plot |
PCPG | rs1020976 | chr10:26935049 | G/C | 0.000146 | 178 | 26.27 | 22.63 | 24.53 | KM Plot |
PCPG | rs10216523 | chr8:126190394 | T/A | 0.000275 | 178 | 25.77 | 25.53 | 4.17 | KM Plot |
PCPG | rs10222564 | chr3:122266336 | T/C | 6.51E-11 | 176 | 24.85 | 28.93 | 5.8 | KM Plot |
PCPG | rs1023152 | chr21:38442706 | C/A | 8.28E-9 | 177 | 25 | 25.87 | 3.83 | KM Plot |
PCPG | rs10266519 | chr7:1142977 | C/T | 0.000362 | 172 | 25.92 | 24.95 | 49.58 | KM Plot |
PCPG | rs10272518 | chr7:33687493 | G/A | 1.28E-7 | 175 | 19.87 | 20.37 | 25.67 | KM Plot |
PCPG | rs10279301 | chr7:156261315 | C/T | 3.79E-5 | 175 | 25.7 | 19.42 | 2.93 | KM Plot |
PCPG | rs1028089 | chr3:80416552 | A/G | 6.39E-7 | 170 | 25.6 | 26.57 | 19.87 | KM Plot |
PCPG | rs1035249 | chr2:172139165 | A/C | 1.18E-7 | 178 | 24.93 | 30.93 | 19.87 | KM Plot |
PCPG | rs10400727 | chr14:74471392 | T/C | 1.85E-6 | 174 | 25.28 | 30.93 | 4.5 | KM Plot |